FRONTIER MEDICINES
Frontier Medicinesโis a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development, enabling patients to consume breakthrough medicines that redefine the course of debilitating diseases.
FRONTIER MEDICINES
Social Links:
Industry:
Artificial Intelligence Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.frontiermeds.com
Total Employee:
11+
Status:
Active
Contact:
650 457 1005
Email Addresses:
[email protected]
Total Funding:
155.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Microsoft Exchange Online Amazon
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
BenchSci
BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.
Current Advisors List
Current Employees Featured
Founder
Investors List
DCVC Bio
DCVC Bio investment in Series B - Frontier Medicines
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Frontier Medicines
Droia Ventures
Droia Ventures investment in Series B - Frontier Medicines
Deep Track Capital
Deep Track Capital investment in Series B - Frontier Medicines
ArrowMark Partners
ArrowMark Partners investment in Series B - Frontier Medicines
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Series B - Frontier Medicines
Deerfield
Deerfield investment in Series B - Frontier Medicines
MPM Capital
MPM Capital investment in Series B - Frontier Medicines
Woodline Partners
Woodline Partners investment in Series B - Frontier Medicines
RA Capital Management
RA Capital Management investment in Series B - Frontier Medicines
Key Employee Changes
Date | New article |
---|---|
2021-11-17 | Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer |
Official Site Inspections
http://www.frontiermeds.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.42 K
- Host name: server-18-245-96-51.yto50.r.cloudfront.net
- IP address: 18.245.96.51
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago